إعلان
إعلان

AKTX

AKTX logo

Akari Therapeutics plc ADR (0.01 USD)

0.29
USD
برعاية
0.00
+1.27%
٠٩ يناير, ١٤:٠٠ UTC -5
مفتوح

تقارير أرباح AKTX

النسبة الإيجابية المفاجئة

AKTX تفوق 8 من 17 آخر التقديرات.

47%

التقرير التالي

بيانات التقرير القادم
١٣ أبريل ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.06
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
--
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
--

Akari Therapeutics plc ADR (0.01 USD) earnings per share and revenue

On ١٣ نوفمبر ٢٠٢٥, AKTX reported earnings of 0.00 USD per share (EPS) for Q3 25, beating the estimate of -0.07 USD, resulting in a 100.00% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.67% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -0.06 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and زيادة of 0.00% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Akari Therapeutics plc ADR (0.01 USD) reported EPS of $0.00, beating estimates by 100%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.67%, changed from $0.52 before the earnings release to $0.53 the day after.
The next earning report is scheduled for ١٣ أبريل ٢٠٢٦.
Based on 5 المحللين, Akari Therapeutics plc ADR (0.01 USD) is expected to report EPS of -$0.06 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان